Biology Reference
In-Depth Information
normal and cancer tissues. Crit Rev Oncol
Hematol 67:39-61
57. Socolovsky M, Nam H, Fleming MD, Haase
VH, Brugnara C, Lodish HF (2001)
Ineffective erythropoiesis in
Stat5a(−/−)5b(−/−) mice due to decreased
survival of early erythroblasts. Blood
98:3261-3273
58. Bao H, Jacobs-Helber SM, Lawson AE, Penta
K, Wickrema A, Sawyer ST (1999) Protein
kinase B (c-Akt), phosphatidylinositol
3-kinase, and STAT5 are activated by erythro-
poietin (EPO) in HCD57 erythroid cells but
are constitutively active in an EPO-
independent, apoptosis-resistant subclone
(HCD57-SREI cells). Blood 93:3757-3773
59. Simon MC, Pevny L, Wiles MV, Keller G,
Costantini F, Orkin SH (1992) Rescue of
erythroid development in gene targeted
GATA-1- mouse embryonic stem cells. Nat
Genet 1:92-98
60. Buck I, Morceau F, Cristofanon S, Heintz C,
Chateauvieux S, Reuter S, Dicato M,
Diederich M (2008) Tumor necrosis factor
alpha inhibits erythroid differentiation in
human erythropoietin-dependent cells involv-
ing p38 MAPK pathway, GATA-1 and FOG-1
downregulation and GATA-2 upregulation.
Biochem Pharmacol 76:1229-1239
61. Ohneda K, Yamamoto M (2002) Roles of
hematopoietic transcription factors GATA-1
and GATA-2 in the development of red blood
cell lineage. Acta Haematol 108:237-245
62. Chong ZZ, Kang JQ, Maiese K (2003) Apaf-
1, Bcl-xL, cytochrome c, and caspase-9 form
the critical elements for cerebral vascular pro-
tection by erythropoietin. J Cereb Blood
Flow Metab 23:320-330
63. Szenajch J, Wcislo G, Jeong JY, Szczylik C,
Feldman L (2010) The role of erythropoietin
and its receptor in growth, survival and thera-
peutic response of human tumor cells From
clinic to bench—a critical review. Biochim
Biophys Acta 1806:82-95
64. Mahmud DL, G-Amlak M, Deb DK, Platanias
LC, Uddin S, Wickrema A (2002)
Phosphorylation of forkhead transcription
factors by erythropoietin and stem cell factor
prevents acetylation and their interaction with
coactivator p300 in erythroid progenitor cells.
Oncogene 21:1556-1562
65. Chong ZZ, Maiese K (2007) Erythropoietin
involves the phosphatidylinositol 3-kinase
pathway, 14-3-3 protein and FOXO3a nuclear
trafficking to preserve endothelial cell integ-
rity. Br J Pharmacol 150:839-850
66. Nagata Y, Todokoro K (1999) Requirement of
activation of JNK and p38 for environmental
stress-induced erythroid differentiation and
apoptosis and of inhibition of ERK for apopto-
sis. Blood 94:853-863
67. Nagata Y, Kiefer F, Watanabe T, Todokoro K
(1999) Activation of hematopoietic progeni-
tor kinase-1 by erythropoietin. Blood
93:3347-3354
68. Kolbus A, Pilat S, Husak Z, Deiner EM,
Stengl G, Beug H, Baccarini M (2002) Raf-1
antagonizes erythroid differentiation by
restraining caspase activation. J Exp Med
196:1347-1353
69. Uddin S, Ah-Kang J, Ulaszek J, Mahmud D,
Wickrema A (2004) Differentiation stage-
specific activation of p38 mitogen-activated
protein kinase isoforms in primary human
erythroid cells. Proc Natl Acad Sci U S A
101:147-152
70. Jacobs-Helber SM, Ryan JJ, Sawyer ST
(2000) JNK and p38 are activated by erythro-
poietin (EPO) but are not induced in apopto-
sis following EPO withdrawal in
EPO-dependent HCD57 cells. Blood 96:
933-940
71. Nagao M, Masuda S, Abe S, Ueda M, Sasaki
R (1992) Production and ligand-binding
characteristics of the soluble form of murine
erythropoietin receptor. Biochem Biophys
Res Commun 188:888-897
72. Fujita M, Takahashi R, Liang P, Saya H,
Ashoori F, Tachi M, Kitazawa S, Maeda S
(1997) Role of alternative splicing of the rat
erythropoietin receptor gene in normal and
erythroleukemia cells. Leukemia 11(Suppl
3):444-445
73. Chikuma M, Masuda S, Kobayashi T, Nagao
M, Sasaki R (2000) Tissue-specific regulation
of erythropoietin production in the murine
kidney, brain, and uterus. Am J Physiol
Endocrinol Metab 279:E1242-E1248
74. Masuda S, Nagao M, Takahata K, Konishi Y,
Gallyas F Jr, Tabira T, Sasaki R (1993)
Functional erythropoietin receptor of the cells
with neural characteristics. Comparison with
receptor properties of erythroid cells. J Biol
Chem 268:11208-11216
75. Brines M, Cerami A (2011) The receptor that
tames the innate immune response. Mol Med
18:486-496
76. Brines M, Cerami A (2005) Emerging bio-
logical roles for erythropoietin in the nervous
system. Nat Rev Neurosci 6:484-494
77. Sinclair AM, Coxon A, McCaffery I, Kaufman
S, Paweletz K, Liu L, Busse L, Swift S, Elliott
S, Begley CG (2010) Functional erythropoi-
etin receptor is undetectable in endothelial,
cardiac, neuronal, and renal cells. Blood
115:4264-4272
Search WWH ::
Custom Search